US Buying $290M Worth Of Anti-Radiation Drugs for Use In "Nuclear Emergency"
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
Stay updated with breaking news from Project Bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
Infowars: There's a War on for your Mind!
The United States Department of Health and Human Services this week announced that it has spent $290 million to purchase drugs for use in radiological and nuclear emergencies.
The U.S. Department of Health and Human Services (HHS) announced this week that the Biden administration agency has procured $290 million worth of a drug used to counter negative health
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...